Sunitinib targets PDGF-receptor and Flt3 and reduces survival and migration of human meningioma cellsNadine Andrae(Otto-von-Guericke University Magdeburg), Christian Mawrin(University Hospital Magdeburg)European Journal of CancerMarch 5, 201210.1016/j.ejca.2012.01.032Cited by 54SaveCiteExport RISWatch citationsRelated PapersThe Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study|The Lancet Neurology|2022|651Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses|Nature Medicine|2023|104